Product Information
MECLIZINE 12.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0464 per EA under NDC 59651080701. Its NADAC has been published 108 times since Jun 5, 2024.
Strength
12.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651080701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202640On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG TABLET has been published 108 times since Jun 5, 2024, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0464 per EA |
|---|---|
| All-time high | $0.0638 (Jul 10, 2024) |
| All-time low | $0.0418 (Nov 20, 2024) |
| 52-week high | $0.0535 |
| 52-week low | $0.0461 |
| Median price | $0.0495 |
| Average price | $0.0512 |
| Largest weekly change | -29.2% (Nov 20, 2024) |
| Weeks tracked | 108 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the MECLIZINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0464 per EA (NDC 59651080701), effective Jun 24, 2026.
How has the price of MECLIZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has declined 6.2%. It has been tracked across 108 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?
Since Jun 5, 2024, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0418 (Nov 20, 2024) to a high of $0.0638 (Jul 10, 2024), with a median of $0.0495 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MECLIZINE 12.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures MECLIZINE 12.5 MG TABLET?
MECLIZINE 12.5 MG TABLET (NDC 59651080701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification